fbpx
QQQ
+ 0.00
324.41
+ 0%
DIA
-0.04
343.69
-0.01%
SPY
-0.04
415.56
-0.01%
TLT
+ 0.00
136.79
+ 0%
GLD
+ 0.02
174.68
+ 0.01%

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

April 6, 2021 9:22 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.

In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelics Industry News Stories for the Week of March 29th – April 4th, 2021.

Without further ado, let’s get started.

Yahoo Finance readers, please click here to view the full article.

10. Red White & Bloom Updates Investors on Acquisitions in Michigan, Illinois and Florida, Celebrates Success of PV and High Times Brands

Demand for RWB’s Platinum Vape Branded Products Continues to Soar, With PV Reporting Record Michigan Sales of Roughly USD $6.5 Million for the Month of February

Red White & Bloom (OTCQX:RWBYF) released a comprehensive Q1 2021 corporate update on Wednesday, bringing investors up to speed on the status of the company’s acquisitions in MichiganIllinois and Florida. The update also celebrated the tremendous success of RWB’s Platinum Vape and High Times cannabis brands.

READ FULL RWB ARTICLE

9. Mexico Marijuana Legalization Bill Clears Key Senate Committee, With Floor Vote Expected This Month

The Senate Justice Committee Approved the Proposal in a 6-5 Tally, With Two More Panels Set to Take it up in the Coming Weeks Before it Goes Before the Full Chamber By the End of the Month

A bill to legalize Marijuana in Mexico is one step closer to final passage. The measure passed the Senate last year but was sent back to the body after being approved in revised form by the Chamber of Deputies. Now, on Monday, a key Senate committee advanced the amended legislation toward a final floor vote.

READ FULL MEXICO ARTICLE

8. Ex-NHL Enforcer Daniel Carcillo Forges New Path Using Psychedelics to Treat TBI, Post-Concussion Syndrome

At Age 30, the NHL Enforcer Was Forced into Early Retirement in 2015 After His Seventh Diagnosed Concussion

After 429 games spread over 11 seasons, capped off by his second Stanley Cup, his career was over. He spent the next four years trying to pull himself out of a debilitating battle with post-concussion syndrome that eventually drove him to be suicidal. But then things changed for Carcillo almost two years ago when he was introduced to Psilocybin through an ex-teammate.

READ FULL DANIEL CARCILLO ARTICLE

7. Illinois Smashes Marijuana Sales Record, Exceeding $100 Million in March

Monthly Marijuana Sales Exceeded $100 Million for the First Time in Illinois in March, Shattering the Previous Record

According to the state Department of Financial and Professional Regulation, adults spent $109,149,355 on recreational Cannabis products in March. That’s nearly $30 million more than the prior month and $20 million more than the last record that was set in January.

READ FULL ILLINOIS ARTICLE

6. Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction

Once Dismissed as a Fringe, Counterculture Vice, Psychedelics Are Rapidly Approaching Acceptance in Mainstream Medicine

These drugs uniquely change the brain, and a person’s awareness of experiences, in the span of just a few hours. This fast-acting shift could be useful in mental-health treatments, and research is already supporting this notion. Just one dose of Psilocybin, the active ingredient in Magic Mushrooms, was recently shown to ease depression and anxiety in cancer patients—an outcome that lasted for years after their trip. Researchers are recognizing that Psychedelics can provide a radical new approach to mental-health treatments at a time when innovation is desperately needed. Ibogaine is one of the most promising psychedelics for addiction. Now, for the first time, some upstart pharmaceutical companies, including ATAI Life Sciences and MindMed (OTCQB:MMEDF), are realizing there’s money to be made here, and they’re racing to develop ibogaine or drugs that act like it.

READ FULL IBOGAINE ARTICLE

5. Why Adult-Use Cannabis Legalization in New York, the Nation’s Financial Hub, is a Big Deal

Sales Are Expected to Start Within 12 to 18 Months Potentially Reach $2.3 Billion a Year By the Program’s Fourth Year

Adult-use Cannabis legalization in New York will produce powerful impacts well beyond the sales generated within the state’s borders, industry experts say. Lawmakers passed the measure late Tuesday night, and Gov. Andrew Cuomo quickly signed the bill into law the next morning.

READ FULL NEW YORK ARTICLE

4. Psychedelics Show Promise in Treatment of Depression, PTSD

What You Know as “Ecstasy” From Some Rave in Your Misspent Youth is Currently Being Studied as a Life-Saving PTSD Therapy

The drug MDMA is being investigated by (among others) the Multidisciplinary Association for Psychedelic Studies (MAPS) to determine whether it will help people cope with the trauma of war, rape or other violent crime. Used in conjunction with psychotherapy for PTSD that doesn’t respond to other treatments, MDMA-assisted therapy is showing positive results.

READ FULL PSYCHEDELICS TREATMENT ARTICLE

3. Bipartisan State Attorneys General Urge Congress to Pass Marijuana Banking Bill

Three State Attorneys General and the Top Prosecutor for Washington, D.C. Sent a Letter to Congressional Leaders, Reiterating Their Support for Legislation That Would Protect Banks That Service State-Legal Marijuana Markets From Being Penalized By Federal Regulators

Rep. Ed Perlmutter (D-CO) is the chief sponsor of the Secure and Fair Enforcement (SAFE) Banking Act in the House, while Sens. Jeff Merkley (D-OR) and Steve Daines (R-MT) are carrying their chamber’s version. Both were reintroduced with substantial bipartisan cosponsor lists last month. Colorado Attorney General Phil Weiser (D) led the new letter, which says that the signatories support the proposal and “encourage Congress to take action expeditiously.”

READ FULL CANNABIS BANKING ARTICLE

2. Third Massachusetts City Approves Psychedelics Decriminalization Measure

Another Massachusetts City Has Approved a Measure to Deprioritize Enforcement of Laws Against the Possession, Use and Distribution of a Wide Range of Psychedelics Such as Psilocybin and Ayahuasca

This time, the Northampton City Council passed the resolution, which also states that no government or police funds should be used to enforce laws criminalizing people for using or possessing entheogenic plants and fungi. The vote on Thursday was unanimous, 8-0, and it makes Northampton the third city in the state to enact the reform. Somerville and Cambridge have also moved to effectively decriminalize Psychedelics.

READ FULL MASSACHUSETTS ARTICLE

1. There are Indications of a Thaw in Glacial Federal Prohibition of Marijuana

With New York’s Governor Signing Adult-Use Marijuana Into Law This Week, The State Joins the Growing Ranks of U.S. Markets Legalizing First-Degree Marijuana Usage

That development continues the trend of states reversing Marijuana prohibition across the country, following on the heels of a letter to the White House last week where 30 Democratic lawmakers urged President Joe Biden to reconsider the decision to fire five White House staffers for marijuana usage. The White House Press Secretary jumped into the fray with a tweet downplaying the controversy.

READ FULL FEDERAL REFORM ARTICLE

Photo by Tim Foster on Unsplash


Related Articles

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week read more

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories of the Week read more

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week read more

Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading

Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. read more